Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2020 - 12 - 04 crawled time : 12:07 save search
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
granted grant nasdaq
Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -0.22%
H: 1.56%
C: -1.85%
granted grant nasdaq
Spero Therapeutics to Provide Business Update and Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Published: 2020-07-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -1.08%
H: 3.78%
C: 2.61%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-07-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
| Email alert
Add to watchlist
granted grant nasdaq
Spero Therapeutics Announces Second Quarter 2020 Operating Results and Provides Business Update
Published: 2020-08-06 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 0.32%
H: 6.72%
C: 1.96%
results
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
Published: 2020-08-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 4.76%
H: 2.5%
C: -1.27%
fda fda acceptance application therapeutics
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Published: 2020-09-08 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 3.35%
H: 54.43%
C: 41.14%
positive results phase 3 trial topline injection infections
Spero Therapeutics Announces Proposed Public Offering
Published: 2020-09-09 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -3.87%
H: 0.65%
C: -9.59%
offering therapeutics publication
Spero Therapeutics Announces Pricing of Securities Offering
Published: 2020-09-11 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -10.57%
H: 4.07%
C: -0.35%
offering therapeutics
Spero Therapeutics to Present at Investor Conferences in September
Published: 2020-09-15 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.91%
H: 2.46%
C: -1.48%
conference presentation therapeutics
Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
Published: 2020-09-24 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -0.64%
H: 4.16%
C: 0.21%
treatment injection infections
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-09-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.88%
H: 4.99%
C: 2.46%
granted grant nasdaq
Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
Published: 2020-10-16 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -0.38%
H: 2.08%
C: 0.23%
program
Spero Therapeutics to Provide Business Update and Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Published: 2020-10-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.97%
H: 1.63%
C: -0.37%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-11-03 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 2.06%
H: 7.33%
C: 5.83%
granted grant nasdaq
Spero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update
Published: 2020-11-05 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 0.07%
H: 1.94%
C: -1.58%
results
Spero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020
Published: 2020-11-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.02%
H: 1.78%
C: -1.95%
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-11-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 1.93%
H: 2.49%
C: 0.53%
granted grant nasdaq
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.